1 – 20 of 22
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
MDM2 amplification in rod-shaped chromosomes provides clues to early stages of circularized gene amplification in liposarcoma
(
- Contribution to journal › Article
- 2023
-
Mark
A cryptic EWSR1::DDIT3 fusion in myxoid liposarcoma: Potential pitfalls with FISH and cytogenetics
(
- Contribution to journal › Article
-
Mark
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
(
- Contribution to journal › Article
- 2022
-
Mark
The diagnostic utility of DNA copy number analysis of core needle biopsies from soft tissue and bone tumors
(
- Contribution to journal › Article
- 2021
-
Mark
Comparative cytological and histological assessment of 828 primary soft tissue and bone lesions, and proposal for a system for reporting soft tissue cytopathology
(
- Contribution to journal › Article
-
Mark
Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients
(
- Contribution to journal › Article
-
Mark
Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight
(
- Contribution to journal › Article
- 2020
-
Mark
Genomic and transcriptomic features of dermatofibrosarcoma protuberans : Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development
(
- Contribution to journal › Article
- 2018
-
Mark
Inflammatory leiomyosarcoma is a distinct tumor characterized by near-haploidization, few somatic mutations, and a primitive myogenic gene expression signature
(
- Contribution to journal › Article
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
- 2015
-
Mark
Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use.
(
- Contribution to journal › Article
- 2014
-
Mark
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
(
- Contribution to journal › Article
- 2013
-
Mark
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.
(
- Contribution to journal › Article
- 2012
-
Mark
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
(
- Contribution to journal › Article
-
Mark
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth
(
- Contribution to journal › Article
-
Mark
Copy Number Defects of G1-Cell Cycle Genes in Neuroblastoma are Frequent and Correlate with High Expression of E2F Target Genes and a Poor Prognosis
(
- Contribution to journal › Article
-
Mark
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
(
- Contribution to journal › Article
- 2009
-
Mark
The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo
(
- Contribution to journal › Article
-
Mark
Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy.
(
- Contribution to journal › Article
- 2008
-
Mark
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma
(
- Contribution to journal › Article